Forte Biosciences, Inc. · NASDAQ:FBRX
Orbimed Advisors LLC reported a 4.30% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Orbimed Advisors LLC reported a 4.30% stake in Forte Biosciences, Inc., 884,230 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 884,230
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 4.30% | 884,230 |
| ORBIMED CAPITAL LLC | 1.50% | 312,725 |
Source
Related
- Forte Biosciences, Inc.
- Orbimed Advisors LLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Feb 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026